Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of DLBS2411 Treatment For Functional Dyspepsia

NCT05248802 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT05248802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05248802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of DLBS2411 Treatment For Functional Dyspepsia
Lead sponsor
Dexa Medica Group
Phase
Phase 3
Overall status
Completed
Start date
December 9, 2022
Completion date
October 1, 2025
Enrollment
106 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

functional dyspepsia